发明名称 |
Disease control with tick phospholipase A2 |
摘要 |
The present invention relates to reagents and methods for the modulation of viability of bacteria. A process is provided wherein a protein sequence from A. americanum saliva effective in reducing the viability of gram positive, gram negative, or acid-fast bacteria and spirochetes including B. burgdorferi is administered. The inventive protein from A. americanum saliva has utility as a therapeutic for the treatment of an organism infected with bacteria, particularly the spirochete B. burgdorferi. |
申请公布号 |
US9468208(B2) |
申请公布日期 |
2016.10.18 |
申请号 |
US201414249503 |
申请日期 |
2014.04.10 |
申请人 |
University of Georgia Research Foundation, Inc.;The United States of America, as represented by the Secretary, Department of Health and Human Services |
发明人 |
Zeidner Nordin;Dolan Marc;Champagne Donald |
分类号 |
A61K38/46;C12N9/20;A01N37/46;A61K38/00 |
主分类号 |
A61K38/46 |
代理机构 |
Dinsmore & Shohl LLP |
代理人 |
Dinsmore & Shohl LLP ;Gould Weston R. |
主权项 |
1. A process of altering the viability of a bacterial organism comprising:
contacting a bacterial organism that is a member of the Spirochaetaceae family or the Treponemataceae family by administering to a vertabrate host infected with the bacterial organism a salivary protein derived from Amblyomma americanum (A. americanum) wherein said protein has phospholipase A2 (PLA2)-like activity. |
地址 |
Athens GA US |